7-115974247-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012252.4(TFEC):c.190G>A(p.Val64Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000164 in 1,587,854 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012252.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TFEC | NM_012252.4 | c.190G>A | p.Val64Ile | missense_variant | 3/8 | ENST00000265440.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TFEC | ENST00000265440.12 | c.190G>A | p.Val64Ile | missense_variant | 3/8 | 1 | NM_012252.4 | P4 | |
TFEC | ENST00000320239.11 | c.180+10015G>A | intron_variant | 1 | A1 | ||||
TFEC | ENST00000484212.5 | c.460G>A | p.Val154Ile | missense_variant | 5/9 | 2 | |||
TFEC | ENST00000393485.5 | c.180+10015G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 151150Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000173 AC: 4AN: 231264Hom.: 0 AF XY: 0.0000318 AC XY: 4AN XY: 125702
GnomAD4 exome AF: 0.0000146 AC: 21AN: 1436704Hom.: 0 Cov.: 29 AF XY: 0.0000154 AC XY: 11AN XY: 714400
GnomAD4 genome AF: 0.0000331 AC: 5AN: 151150Hom.: 0 Cov.: 31 AF XY: 0.0000136 AC XY: 1AN XY: 73768
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.190G>A (p.V64I) alteration is located in exon 3 (coding exon 2) of the TFEC gene. This alteration results from a G to A substitution at nucleotide position 190, causing the valine (V) at amino acid position 64 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at